Richard Ranieri
Vermögen: 162 863 $ am 31.05.2026
Vermögen: 162 863 $ am 31.05.2026
Richard J.
Ranieri is an Independent Director at Xencor, Inc. since 2017.
Formerly, Mr. Ranieri was Senior VP-Human Resources & Corporate Affairs at BioMarin Pharmaceutical, Inc. from 2013 to 2019.
Served as Executive Vice President-Human Resources at Dendreon Corp.
from 2011 to 2013.
Held the position of EVP-Human Resources & Administration at Sumitomo Pharma America, Inc. from 2008 to 2011.
Worked as Chief Administrative Officer & SVP-Human Resources at Neurocrine Biosciences, Inc. in 2008.
Was Senior Vice President-Human Resources at Genencor International, Inc. from 1993 to 2005.
Also held the title of Principal at GlaxoSmithKline LLC.
Education includes graduate studies at Rider University and undergraduate studies at Villanova University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XENCOR, INC. 0,02 % | 15.06.2026 | 13.709 ( 0,02 % ) | 162 863 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| XENCOR, INC. | Direktor/Vorstandsmitglied | 19.12.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Personalreferent | 01.01.2019 |
| DENDREON CORPORATION | Personalreferent | 01.01.2013 |
| NEUROCRINE BIOSCIENCES, INC. | Verwaltungsdirektor | 01.08.2008 |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Personalreferent | 01.01.2005 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Xencor, Inc.
Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Rider University
Rider University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen